These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7010372)

  • 21. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638.
    Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G
    Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun; 3(24):107. PubMed ID: 7693194
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins.
    Satchell KJ
    Microbes Infect; 2003 Nov; 5(13):1241-7. PubMed ID: 14623020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of Vibrio antibody titers during anti-cholera vaccination].
    Dirimci OT; Cinar V
    Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):118-28. PubMed ID: 4807572
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation and characterisation of a non-toxinogenic mutant of V. cholerae and possibility of a live oral cholera vaccine.
    Datta A; Sasmal D; Datta GC; Pal SC
    Indian J Med Res; 1977 Jun; 65(6):770-6. PubMed ID: 604253
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cholera research 100 years after its discovery--current topics].
    Zinnaka Y
    Nihon Saikingaku Zasshi; 1984 Jul; 39(4):713-31. PubMed ID: 6094878
    [No Abstract]   [Full Text] [Related]  

  • 27. An oral cholera vaccine for travelers (Vaxchora).
    Med Lett Drugs Ther; 2016 Aug; 58(1502):113-4. PubMed ID: 27552209
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of oral cholera vaccines during pregnancy in developing countries.
    Khan AI; Islam MT; Qadri F
    Hum Vaccin Immunother; 2017 Oct; 13(10):2245-2246. PubMed ID: 28825876
    [No Abstract]   [Full Text] [Related]  

  • 29. Pathogenesis and prevention of cholera.
    Holmgren J
    Scand J Infect Dis Suppl; 1982; 36():58-64. PubMed ID: 6963754
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of cholera.
    Preston NW
    Lancet; 2004 Mar; 363(9412):898. PubMed ID: 15031046
    [No Abstract]   [Full Text] [Related]  

  • 31. [Selection of attenuated Vibrio cholerae strains to obtain oral attenuated candidate vaccines against cholera].
    María García H; Año G; Cedré B; Valmaseda T; Maestre JL; Díaz M; Mirabal M; Talavera A; García L
    Rev Cubana Med Trop; 2005; 57(2):92-104. PubMed ID: 17966578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cholera 2].
    Bol P
    Ned Tijdschr Tandheelkd; 2000 May; 107(5):215-6. PubMed ID: 11385820
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against cholera: what prospects?].
    Pierre P; Lucas G; Vaerman JP
    Ann Soc Belg Med Trop; 1988 Jun; 68(2):83-93. PubMed ID: 3071278
    [No Abstract]   [Full Text] [Related]  

  • 34. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
    Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea.
    Sánchez J; Holmgren J
    Curr Opin Immunol; 2005 Aug; 17(4):388-98. PubMed ID: 15963708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.
    Yang JS; Kim HJ; Yun CH; Kang SS; Im J; Kim HS; Han SH
    J Microbiol Methods; 2007 Nov; 71(2):141-6. PubMed ID: 17888533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of antibody responses and protective immunity in cholera vaccinated subjects.
    Chaicumpa W; Pacharaprakiti C; Plueksawan W; Atthasishtha N
    Southeast Asian J Trop Med Public Health; 1980 Mar; 11(1):58-66. PubMed ID: 7403955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholera in Europe today].
    Dal Fabbro G
    Minerva Med; 1972; 63(7):409-12. PubMed ID: 4664871
    [No Abstract]   [Full Text] [Related]  

  • 39. [The prospects for improving chemical cholera vaccines].
    Markov EIu; Maramovich AS; Golubinskiĭ EP; Urbanovich LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):91-6. PubMed ID: 9783412
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
    Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
    Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.